Breast Cancer
Trial updates from ESMO Breast Cancer 2022: TUXEDO-1, monarchE, KEYNOTE-355
The European Society for Clinical Oncology (ESMO) Breast Cancer Conference was a hybrid event, held virtually and Berlin, Germany. This…
Date: 16th May 2022
Novel treatment approaches in HR+/HER2- breast cancer
Resistance to endocrine therapy in patients with hormone-receptor positive (HR+), HER2-negative breast cancer inevitably results in relapse and metastasis, leading…
Date: 25th March 2022
The Breast Cancer Sessions: Highlights from SABCS 2021
The San Antonio Breast Cancer Symposium (SABCS) 2021 saw ground-breaking data and developments in breast cancer being presented and in…
Date: 11th March 2022
Updates on HER2-positive breast cancer
HER2-positive breast cancer accounts for 15-20% of all breast cancer cases. It was associated with a poor prognosis until the…
Date: 15th February 2022
Breast Cancer Sessions: Highlights from SABCS 2021 with Lisa Carey & Aleix Prat
The San Antonio Breast Cancer Symposium 2021 featured exciting developments in early and advanced breast cancer, basic science, and translational…
Date: 14th January 2022
Immunotherapy updates from SABCS 2021 with Heather McArthur & Kevin Kalinsky
The success of immunotherapy in the treatment of solid tumors has created hope for its potential in breast cancer. The…
Date: 4th January 2022
The Breast Cancer Sessions: Highlights from ASCO 2021
VJOncology has assembled an international panel of leading breast cancer experts to discuss the latest advances and data from the…
Date: 18th August 2021
What’s new? Treating breast cancer with brain metastases
Metastatic breast cancer is breast cancer that has spread to other regions of the body, most commonly the liver, brain,…
Date: 13th July 2021
Global breast cancer care
Healthcare systems around the world differ in financial and political situations. Therefore, it is vital to implement a global outlook…
Date: 13th July 2021
ESMO Breast 2021: updates on immunotherapy
Breast cancer is the most common type of cancer in women. Although most cases of early-stage non-metastatic disease are curable…
Date: 10th June 2021
Sequencing HER2-targeting therapies in the metastatic breast cancer space
Treatment approaches in breast cancer are multimodal, and with the onset of novel immunotherapies and targeted agents, the therapeutic landscape…
Date: 14th May 2021
The Breast Cancer Sessions: a focus on the St. Gallen Consensus
At the 17th St. Gallen International Breast Cancer Conference 2021, leading experts gathered virtually to take part in the renowned…
Date: 26th April 2021
